ASX:ACW - XanaHES Trial to Continue

Investor Hub

Announcements & Reports

ASX Announcements Analyst Research Annual Reports Financial Results Corporate Presentations

Shareholders

Annual General Meeting General Meeting Financial Calendar Right to Receive Documents Investor Contacts FAQs

News

News Media Press Releases Company Updates

Back to Actinogen

XanaHES Trial to Continue

Your question will be sent privately to Actinogen. The company may choose to make this question public.

Start the conversation

Ask Actinogen a question about this announcement.

Share your feedback

Discover

Investor Hub

Powered by InvestorHub•Terms and conditions•Privacy policy•Cookie settings•Contact